After five years at No. 1 in Surescripts’ Safe-Rx Awards, Massachusetts drops to No. 2 in the rankings of highest e-prescribing use in the nation during 2011.
Surescripts announced that Minnesota achieved the highest rate of e-prescribing use in the nation during 2011 to capture the No. 1 ranking in its seventh annual Safe-Rx Awards. After a five-year run at No. 1, Massachusetts falls to No. 2.
The rankings are determined by an analysis of data that measures electronic prescribing use by physicians, pharmacies and payers in each state. The top 10 states with the highest rates of e-prescribing, according to Surecripts, are:
1. Minnesota
2. Massachusetts
3. South Dakota
4. Delaware
5. New Hampshire
6. Iowa
7. North Carolina
8. Maine
9. Vermont
10. Michigan
Growth in the adoption and use of e-prescribing – which includes prescription routing, utilization of benefit information and utilization of medication history – created the most changes in the rankings over its seven-year history. According to Surescripts, the data indicates that state and federal initiatives to increase the adoption and use of e-prescribing by healthcare providers are significant drivers in e-prescribing’s growth.
Highlights from the rankings include:
Go back to the Managed Healthcare Executive eNews newsletter.
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with CeCi Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
March 26th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and CeCi Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
What States are Doing to Regulate Pharmacy Benefit Managers
March 26th 2024In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers found that state-level PBM reform focused on more transparent drug pricing, better patient access to prescription drugs, and more stringent auditing and reporting requirements.
Read More
FDA Approves Combination Therapy for Pulmonary Arterial Hypertension
March 26th 2024J&J’s Opsynvi is single-tablet combination of macitentan, an endothelin receptor antagonist, and tadalafil, a PDE5 inhibitor. It will be priced on parity with Opsumit, which is also a J&J product to treat patients with PAH.
Read More